Nos publications
Mise à jour août 2024
Pagination
- Page précédente
- Page 10
- Page suivante
Title | Authors | Year Trier par ordre croissant | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia | Giles JB, Steiner HE, Rollin J, Shaffer CM, Momozawa Y, Mushiroda T, Inai C, Selleng K, Thiele T, Pouplard C, Heddle NM, Kubo M, Miller EC, Martinez KL, Phillips EJ, Warkentin TE, Gruel Y, Greinacher A, Roden DM, Karnes JH | 2022 | Blood Adv | View Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia | Researchers | Basic research |
Plasma transfusion practices: A multicentre electronic audit | Khandelwal A, Minuk L, Liu Y, Arnold DM, Heddle NM, Barty R, Hsia C, Solh Z, Shehata N, Thompson T, Tinmouth A, Perelman I, Skeate R, Kron AT, Callum J | 2022 | Vox Sang | View Plasma transfusion practices: A multicentre electronic audit | Health care providers | Clinical research |
Circular of information for the use of human blood components: Whole Blood | Stewart T | 2022 | Blood.ca website | View Circular of information for the use of human blood components: Whole Blood | Health care providers | Benchmarking and standard setting |
Circular of information for the use of human blood components: Plasma Components | Stewart T | 2022 | Blood.ca website | View Circular of information for the use of human blood components: Plasma Components | Health care providers | Benchmarking and standard setting |
The Market in Noninvasive Prenatal Tests and the Message to Consumers: Exploring Responsibility | Holloway K, Simms N, Hayeems RZ, Miller FA | 2022 | Hastings Cent Rep | View The Market in Noninvasive Prenatal Tests and the Message to Consumers: Exploring Responsibility | Regulators | Ethical, legal and social implications research |
Complement contributions to COVID-19 | Conway EM, Pryzdial ELG | 2022 | Curr Opin Hematol | View Complement contributions to COVID-19 | Researchers | Basic research |
Balancing non-discriminatory donor selection and blood safety in the Netherlands: Evaluation of an individual risk assessment of sexual behavior | Hahn B, Quee F, Prinsze FJ, Gregoire Y, O'Brien SF, Germain M, van de Laar T, Zaaijer HL, van den Hurk K | 2022 | Transfusion | View Balancing non-discriminatory donor selection and blood safety in the Netherlands: Evaluation of an individual risk assessment of sexual behavior | Blood operators | MSM research |
Evolving policies for donors with diabetes: The Canadian experience | Miller O, Caffrey N, O'Brien SF, Goldman M | 2022 | Vox Sang | View Evolving policies for donors with diabetes: The Canadian experience | Researchers | New or improved product or process |
Chapter 17. Hemostatic disorders and hereditary angioedema | Poon MC, Goodyear D, Rydz N, Lee A | 2022 | Clinical Guide to Transfusion | View Chapter 17. Hemostatic disorders and hereditary angioedema | Health care providers | Benchmarking and standard setting |
Assessing the quality of stored red blood cells using handheld Spatially Offset Raman spectroscopy with multisource correlation analysis | Vardaki MZ, Georg Schulze H, Serrano K, Blades MW, Devine DV, F. B. Turner R | 2022 | Spectrochim Acta A Mol Biomol | View Assessing the quality of stored red blood cells using handheld Spatially Offset Raman spectroscopy with multisource correlation analysis | Researchers | New or improved product or process |
Acute thrombocytopenia suggesting thrombotic microangiopathy | Venier LM, Patriquin CJ, Warkentin TE | 2022 | Am J Hematol | View Acute thrombocytopenia suggesting thrombotic microangiopathy | Health care providers | Clinical research |
An uncertain association between influenza season, recent influenza vaccination campaigns, and unconfirmed repeat reactive syphilis serology assay results in Canadian blood donors | Drews SJ, Bodnar M, Gill B, Carson D, Hawes G, Yi QL, Tran V, Zhou HY, Bigham M, O'Brien SF | 2022 | Transfusion | View An uncertain association between influenza season, recent influenza vaccination campaigns, and unconfirmed repeat reactive syphilis serology assay results in Canadian blood donors | Researchers | Benchmarking and standard setting |
A Qualitative Comparison of the Abbott SARS-CoV-2 IgG II Quant Assay against Commonly Used Canadian SARS-CoV-2 Enzyme Immunoassays in Blood Donor Retention Specimens, April 2020 to March 2021 | Abe KT, Rathod B, Colwill K, Gingras A-C, Tuite A, Robbins NF, Orjuela G, Jenkins C, Conrod V, Yi Q-L, O’Brien SF, Drews SJ | 2022 | Microbiol Spectr | View A Qualitative Comparison of the Abbott SARS-CoV-2 IgG II Quant Assay against Commonly Used Canadian SARS-CoV-2 Enzyme Immunoassays in Blood Donor Retention Specimens, April 2020 to March 2021 | Researchers | Benchmarking and standard setting |
Blood is a politic of place-making: Blackness, queerness and the construction of the donor | Dryden OH | 2022 | Harriet’s Legacies: Race, Historical Memory, and Futures in Canada | View Blood is a politic of place-making: Blackness, queerness and the construction of the donor | Researchers | MSM research |
Automated closed volume reduction process for apheresis stem cell grafts: From development to clinical implementation | Howell A, Letcher B, Murphy K, Elmoazzen H, Petraszko T, Acker JP, Pineault N, Holovati JL | 2022 | Transfusion | View Automated closed volume reduction process for apheresis stem cell grafts: From development to clinical implementation | Researchers | New or improved product or process |
A data-informed system to manage scarce blood product allocation in a randomized controlled trial of convalescent plasma | Li N, Zeller MP, Shih AW, Heddle NM, St. John M, Bégin P, Callum J, Arnold DM, Akbari-Moghaddam M, Down DG, Jamula E, Devine DV, Tinmouth A | 2022 | Transfusion | View A data-informed system to manage scarce blood product allocation in a randomized controlled trial of convalescent plasma | Researchers | Clinical research |
Rapport de surveillance | O'Brien SF | 2022 | Blood.ca website | View Rapport de surveillance | Blood operators | Benchmarking and standard setting |
Current status of rapid bacterial detection methods for platelet components: A 20-year review by the ISBT Transfusion-Transmitted Infectious Diseases Working Party Subgroup on Bacteria | Schmidt M, Ramirez-Arcos S, Stiller L, McDonald C, ISBT Transfusion-Transmitted Infectious Diseases Working Party Subgroup on Bacteria | 2022 | Vox Sang | View Current status of rapid bacterial detection methods for platelet components: A 20-year review by the ISBT Transfusion-Transmitted Infectious Diseases Working Party Subgroup on Bacteria | Researchers | Benchmarking and standard setting |
2021 Chinese consensus on the diagnosis and management of primary immune thrombocytopenia in pregnancy | Zhang X, Chen F, Chen X, Cheng Y, Fang M, Feng J, Fu H, Gao H, Han Y, He A, Hou M, Hu Y, Huang R, Huang W, Jing Z, Kong P, Liang A, Liang M, Liu D, Liu J, Liu L, Liu X, Ma L, Mei H, Ni H, Niu T, Peng J, Qiao J, Ren J, Song Y, Tang LV, Tong T, Wang S, Wang X, Wang Z, Wei H, Wu D, Wu G, Xu C, Xu X, Xu Y, Yang L, Yang R, Yang T, Yin C, Yu L, Zhang G, Zhang L, Zhang L, Zhang X, Zhao W, Zhao Y, Zhou D, Zhou H, Zhou Z, Zhu T, Wang J, Huang X | 2022 | Chin Med J (Engl) | View 2021 Chinese consensus on the diagnosis and management of primary immune thrombocytopenia in pregnancy | Health care providers | Clinical research |
International Forum on the Management of Major Haemorrhage: Summary | Green L, Stanworth S, McQuilten Z, Lin V, Tucker H, Jackson B, Badawi M, Hindawi S, Chaurasia R, Patidar G, Pandey HC, Fasola F, Miyata S, Matsumoto M, Matsushita T, Rahimi-Levene N, Peer V, Pavenski K, Callum J, Thompson T, Murphy M, Staves J, Maegele M, Abeyakoon C, Rushford K, Wood E, Nuñez MA, Mellado S, Saa E, Triyono T, Pratomo B, Apelseth TO, Dunbar N | 2022 | Vox Sang | View International Forum on the Management of Major Haemorrhage: Summary | Health care providers | Benchmarking and standard setting |
Reply to: Concerns about estimating relative risk of death associated with convalescent plasma for COVID-19 | Bégin P, Callum J, Cook R, Jamula E, Liu Y, Finzi A, Arnold DM | 2022 | Nat Med | View Reply to: Concerns about estimating relative risk of death associated with convalescent plasma for COVID-19 | Researchers | Clinical research |
Removing the men who have sex with men blood donation deferral: Informing risk models using Canadian public health surveillance data | Caffrey N, Goldman M, Lewin A, Grégoire Y, Yi QL, O’Brien SF | 2022 | Transfus Clin Biol | View Removing the men who have sex with men blood donation deferral: Informing risk models using Canadian public health surveillance data | Researchers | MSM research |
SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada: a cross-sectional study | Goldfarb DM, Mâsse LC, Watts AW, Hutchison SM, Muttucomaroe L, Bosman ES, Barakauskas VE, Choi A, Dhillon N, Irvine MA, Reicherz F, O’Reilly C, Sediqi S, Xu RY, Razzaghian HR, Sadarangani M, Coombs D, O’Brien SF, Lavoie PM | 2022 | BMJ Open | View SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada: a cross-sectional study | Researchers | Clinical research |
Doxorubicin-Induced Platelet Activation and Clearance Relieved by Salvianolic Acid Compound: Novel Mechanism and Potential Therapy for Chemotherapy-Associated Thrombosis and Thrombocytopenia | Ma W, Rousseau Z, Slavkovic S, Shen C, Yousef GM, Ni H | 2022 | Pharmaceuticals | View Doxorubicin-Induced Platelet Activation and Clearance Relieved by Salvianolic Acid Compound: Novel Mechanism and Potential Therapy for Chemotherapy-Associated Thrombosis and Thrombocytopenia | Researchers | Basic research |
Circulaire d'information utilisation de composants sanguins humains: Plaquettes | Stewart T | 2022 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Plaquettes | Health care providers | Benchmarking and standard setting |
Circular of information for the use of human blood components: Pathogen Reduced Platelet Concentrates | Stewart T | 2022 | Blood.ca website | View Circular of information for the use of human blood components: Pathogen Reduced Platelet Concentrates | Health care providers | Benchmarking and standard setting |
International Forum on Gender Identification and Blood Collection: Summary | Pandey S, Gorlin JB, Townsend M, Van Buren N, Leung JNS, Lee CK, van den Hurk K, Casamitjana N, Valles R, Alonso E, Miller YM, Richard P, Woimant G, Tiberghien P, Zhiburt E, Butler-Foster T, Goldman M, Nissen-Meyer LSH, Espinosa A, Kamel H, Bravo M, Filho LA, Pecego M, Germain M, Rabusseau I, Shinar E, Raz H, Choudhury N, Bhatnagar N, Hurt K, Lopez M, Reik RA, Nie Y, Hung Y, Pheello L, Dunbar N | 2022 | Vox Sang | View International Forum on Gender Identification and Blood Collection: Summary | Blood operators | Benchmarking and standard setting |
ResearchUnit: Whole blood: longer holding times before leukoreduction may be a safe to explore option | Chen ZY | 2022 | Blood.ca website | View ResearchUnit: Whole blood: longer holding times before leukoreduction may be a safe to explore option | Regulators | New or improved product or process |
Spotlight on animal models of acute traumatic coagulopathy: An update | Ask A, Eltringham-Smith L, Bhakta V, Donkor DA, Pryzdial ELG, Sheffield WP | 2022 | Transfus Apher Sci | View Spotlight on animal models of acute traumatic coagulopathy: An update | Researchers | Basic research |
A naturally present autoantibody to senescent red blood cells? | Badior KE, Bloch EM, Branch DR | 2022 | Transfusion | View A naturally present autoantibody to senescent red blood cells? | Researchers | Benchmarking and standard setting |
Opposing roles of CLK SR kinases in controlling HIV-1 gene expression and latency | Dahal S, Clayton K, Been T, Fernet-Brochu R, Ocando AV, Balachandran A, Poirier M, Maldonado RK, Shkreta L, Boligan KF, Guvenc F, Rahman F, Branch D, Bell B, Chabot B, Gray-Owen SD, Parent LJ, Cochrane A | 2022 | Retrovirology | View Opposing roles of CLK SR kinases in controlling HIV-1 gene expression and latency | Researchers | Basic research |
A data-driven approach to determine daily platelet order quantities at hospitals | Mirjalili M, Abouee-Mehrizi H, Barty R, Heddle NM, Sarhangian V | 2022 | Transfusion | View A data-driven approach to determine daily platelet order quantities at hospitals | Researchers | New or improved product or process |
Chapitre 5. Concentrés pour les troubles de l’hémostase et l’angiœdème héréditaire | Poon MC, Goodyear D, Rydz N, Lee A | 2022 | Guide de la pratique transfusionnelle | View Chapitre 5. Concentrés pour les troubles de l’hémostase et l’angiœdème héréditaire | Health care providers | Benchmarking and standard setting |
Circulaire d'information utilisation de composants sanguins humains: Plaquettes | Jenkins C | 2021 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
Screening of Feijoa (Acca Sellowiana (O. Berg) Burret) Fruit Effect on Proliferation and Apoptosis using Bone Marrow derived Stem Cells Model | Rasekh H, Mahrabani D, Hosseini Farahi M, Masoumi S, Acker J | 2021 | Electron J Gen Med | View Screening of Feijoa (Acca Sellowiana (O. Berg) Burret) Fruit Effect on Proliferation and Apoptosis using Bone Marrow derived Stem Cells Model | Researchers | Basic research |
Determinants of the intention to participate in a programme of plasma donation for fractionation among men who have sex with men | Veillette-Bourbeau L, Otis J, Lewin A, Godin G, Germain M, Daunais-Laurin G, Lalonde F, Caruso J, Myhal G, Pronovost F | 2021 | Vox Sang | View Determinants of the intention to participate in a programme of plasma donation for fractionation among men who have sex with men | Researchers | MSM research |
Viper venoms drive the macrophages and hepatocytes to sequester and clear platelets: novel mechanism and therapeutic strategy for venom-induced thrombocytopenia | Shen C, Liu M, Mackeigan DT, Chen ZY, Chen P, Karakas D, Li J, Norris PAA, Li J, Deng Y, Long C, Lai R, Ni H | 2021 | Arch Toxicol | View Viper venoms drive the macrophages and hepatocytes to sequester and clear platelets: novel mechanism and therapeutic strategy for venom-induced thrombocytopenia | Researchers | Basic research |
Recommendations for the clinical and laboratory diagnosis of VITT against COVID-19: Communication from the ISTH SSC Subcommittee on Platelet Immunology | Nazy I, Sachs UJ, Arnold DM, McKenzie SE, Choi P, Althaus K, Ahlen MT, Sharma R, Grace RF, Bakchoul T | 2021 | J Thromb Haemost | View Recommendations for the clinical and laboratory diagnosis of VITT against COVID-19: Communication from the ISTH SSC Subcommittee on Platelet Immunology | Health care providers | Benchmarking and standard setting |
Aspirin nonsensitivity in patients with vascular disease: Assessment by light transmission aggregometry (aspirin nonsensitivity in vascular patients) | Khan H, Zamzam A, Gallant RC, Syed MH, Rand ML, Ni H, Forbes TL, Al-Omran M, Qadura M | 2021 | Res Pract Thromb Haemost | View Aspirin nonsensitivity in patients with vascular disease: Assessment by light transmission aggregometry (aspirin nonsensitivity in vascular patients) | Researchers | Clinical research |
Chapitre 2: Les composants sanguins | Gupta A, Bigham M | 2021 | Guide de la pratique transfusionnelle | View Chapitre 2: Les composants sanguins | Health care providers | Benchmarking and standard setting |
A comparative study of platelet factor 4-enhanced platelet activation assays for the diagnosis of heparin-induced thrombocytopenia | Rubino JG, Arnold DM, Warkentin TE, Smith JW, Kelton JG, Nazy I | 2021 | J Thromb Haemost | View A comparative study of platelet factor 4-enhanced platelet activation assays for the diagnosis of heparin-induced thrombocytopenia | Researchers | Basic research |
Donor screening question alternatives to men who have sex with men time deferral: Potential impact on donor deferral and discomfort | O'Brien SF, Goldman M, Robillard P, Osmond L, Myhal G, Roy É | 2021 | Transfusion | View Donor screening question alternatives to men who have sex with men time deferral: Potential impact on donor deferral and discomfort | Blood operators | MSM research |
Differential Leukocyte MicroRNA Responses Following Pan T Cell, Allorecognition and Allosecretome-Based Therapeutic Activation | Yang X, Toyofuku WM, Scott MD | 2021 | Arch Immunol Ther Exp | View Differential Leukocyte MicroRNA Responses Following Pan T Cell, Allorecognition and Allosecretome-Based Therapeutic Activation | Researchers | Basic research |
Anemia-Induced Bleeding in Patients with Platelet Disorders | Thakar S, Gabarin N, Gupta A, Radford M, Warkentin TE, Arnold DM | 2021 | Transfus Med Rev | View Anemia-Induced Bleeding in Patients with Platelet Disorders | Health care providers | Clinical research |
Soy Isoflavones Inhibit Both GPIb-IX Signaling and ?IIb?3 Outside-In Signaling via 14-3-3? in Platelet | Liu M, Wang G, Xu R, Shen C, Ni H, Lai R | 2021 | Molecules | View Soy Isoflavones Inhibit Both GPIb-IX Signaling and ?IIb?3 Outside-In Signaling via 14-3-3? in Platelet | Researchers | Basic research |
Degradation of red blood cell deformability during cold storage in blood bags | Islamzada E, Matthews K, Lamoureux ES, Duffy SP, Scott MD, Ma H | 2021 | eJHaem | View Degradation of red blood cell deformability during cold storage in blood bags | Researchers | Basic research |
Patterns of joint damage in severe haemophilia A treated with prophylaxis | Goren R, Pullenayegum E, Blanchette VS, Dover S, Carcao M, Israels SJ, Chan A, Rivard GE, Steele M, Cloutier S, Klaassen RJ, Sinha R, Price VE, Laferriere N, Paradis E, Wu JK, Feldman BM | 2021 | Haemophilia | View Patterns of joint damage in severe haemophilia A treated with prophylaxis | Health care providers | Clinical research |
Qualitative study to support the content validity of the immune thrombocytopenia (ITP) Life Quality Index (ILQI) | Cooper N, Cuker A, Bonner N, Ghanima W, Provan D, Morgan M, Taylor B, D'Alessio D, Arnold D, Viana R | 2021 | Br J Haematol | View Qualitative study to support the content validity of the immune thrombocytopenia (ITP) Life Quality Index (ILQI) | Health care providers | Benchmarking and standard setting |
Trauma 2021: Trauma Association of Canada Annual Scientific Meeting, Vancouver, British Columbia (virtual), April 12–16, 2021 | Bednarek O, O’Leary M, Hurley S, Cummings C, Bird R, Frattini S, McEachern S, Benjamin S, Pereira A, Brigode W, MacLean A, Moore L, Makish A, Sadler J, Sadler J, Albacete S, Forbes H, Grzelak S, Strauss R, Strauss R, Upadhyaya Y, Leung V, Tropiano J, Moore M, Greene J, Goldstein J, Schmitz E, Bratu I, Alballa AS, Dawe P, Malone J, Javidan AP, Allen L, Curtis RM, Ssebazza K, Schellenberg M, Lampron J, Tanenbaum B, Chisholm A, Ringuette J, Watson I, Shi D, Bhangu A, Moffat B, Fong D, Moore L, Farquharson S, Al Khaboori S, Lorthios-Guilledroit A, Côté C, McPherson J, Tran A, Guttman M, Yeung M, Poirier R-A, Siddiqi M, Evans T, Guiab K, Guiab K, Bradley N, Elliott C, Bradley N, Power A, Kirkpatrick A, Merkle A, Jessula S, Minor S, Emsley J, Sameoto C, Fitzpatrick E, Erdogan M, Lampron J, Green R, Sibley A, Jain T, Nicholson B, Stryhn H, Karsli C, Stuhler R, Ng E, Coates A, Engels P, Benjamin S, Watson I, Watson I, Talsma AN, Lobchuk M, Thongpriwan V, Cahill S, Mis J, Starr F, Bokhari F, Ladak A, Snelgrove R, Wang H, Power H, Bradley N, Allen L, Leeper R, Parry N, Ball I, Vogt K, Moffat B, Rawls D, Dawe P, Ramler G, Andres E, Rawls D, Lakha N, Brisson A, Merchant J, Forbes H, Widder S, Bradley N, Bradley N, Widder S, Albacete S, Berube M, Gagnon M-A, Pelet S, Belzile É, Kron A, Callum J, Armali C, Modi D, Notario L, Perez P, Tillmann B, Pannell D, Beckett A, Tien H, Nathens A, Da Luz L, Perrier L, Menchetti I, Blondal E, Peng H, Sullivan-Kwantes W, Tien H, Nathens A, Beckett A, Callum J, Da Luz L, Irfan N, Coates A, Engels P, Razek T, Wilson A, Beckett A, Goltz D, Figueira S, Knight H, Lampron J, Devine D, Callum J, Jenkins C, Beckett A, Goldstien J, Leroux Y, McVey J, Brown R, Swain J, Carter A, Fidgen D, Baker S, Butts F, McCulloch S, Opra I, Jensen J, Travers A, Andreou P, Earl M, Warner G, Carter A, Rezaaifar M, Figueira S, Wilkins D, Lampron J, Lai K, Hafeez AA, Goldberg S, Abahuje E, Pozner C, Yule S, Parker S, Dias R, Simons R, Joos E, Haines VV, Linder J, Cameron A, Nathens A, Cleghorn G, Chaplin T, Vogt K, Parry N, Priestap F, Leeper R, Mujoomdar A, Kribs S, Ball I, Kearley C, LeBlanc J, Owattanapanich N, Getrajdman J, Matsushima K, Lam L, Inaba K, Figueira S, Eagles D, Khoury L, Nemnom M-J, Moors J, Kriellaars D, Mitchell D, Watson I, Totton L, Ouelett L, Benjamin S, Vautour J, McEachern S, Watson I, Ouelett L, Ringuette J, Chisholm A, Pishe T, McLaren C, Evans C, Notario L, Pannell D, Thomas-Boaz W, Freedman C, Tien H, Nathens A, Da Luz L, Li C, Vogt K, Allen L, Yoshy C, Mujoomdar A, Wiseman D, Mao R, Liu EY, Lan L, Amir T, Yan J, Singh K, Allard-Coutu A, Hameed M, Garraway N, Joos E, Isac G, Kanji H, Finlayson G, Tansley G, Lee A, Gonthier C, Belcaïd A, Moore L, Duranceau M-F, Truchon C, Berube M, Moore L, Lauzier F, Vogt K, Berry G, Tremblay L, Martel M, Pagé G, Belzile É, Pinard A-M, Evans D, Perreault K, Sirois C, Grzelak S, Turgeon A, Talbot M, Kennedy C, Hilsden R, Slobogean G, Lamb T, Lampron J, Matar M, Fernando S, Perry J, Vaillancourt C, Nathens J, Strauss R, Tillmann B, Phillips A, Haas B, Hage B, Yanchar N, Joos E, Brisson A, McKay J, Bryan F, Evans T, Qureshi A, Saadat G, Khalifa A, Bokhari F, Kaminsky M, Guiab K, Khalifa A, Bokhari F, Aly A, Evans T, Roberts A, Khalifa A, Kaminsky M, Bokhari F, Evans T, Zahid J, Roberts A, Saadat G, Messer T, Bokhari F, Keen R, Hoogers K, Widder S, Notario L, Javidan A, Johnston M, Thomas-Boaz W, Freedman C, Pannell D, Tien H, Nathens A, Da Luz L, Morch K, Scott L, Lam N, Widder S, Parekh A, Parry N, Tomlinson C, Donley N, McKee J, Wachs J, Kay M, Holland S | 2021 | Can J Surg | View Trauma 2021: Trauma Association of Canada Annual Scientific Meeting, Vancouver, British Columbia (virtual), April 12–16, 2021 | Health care providers | Basic research |
Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): Study protocol for an international, multicenter, randomized open-label trial | Bégin P, Callum J, Heddle N, Cook R, Zeller MP, Tinmouth A, Fergusson D, Cushing MM, Glesby MJ, Chassé M, Devine DV, Robitaille N, Bazin R, Shehata N, Finzi A, McGeer A, Scales D, Schwartz L, Turgeon AF, Zarychanski R, Daneman N, Carl R, Amorim L, Gabe C, Ellis M, Jamula E, Carruthers J, Duncan J, Lucier K, Armali C, Kron A, Modi D, Auclair M-C, Avram M, Arnold DM | 2021 | Trials | View Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): Study protocol for an international, multicenter, randomized open-label trial | Researchers | Clinical research |